These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8159101)
1. Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements. Proudler AJ; Godsland IF; Stevenson JC Metabolism; 1994 Apr; 43(4):446-9. PubMed ID: 8159101 [TBL] [Abstract][Full Text] [Related]
2. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Kahn SE; Halban PA Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018 [TBL] [Abstract][Full Text] [Related]
4. Insulin and insulin propeptides at birth in offspring of diabetic mothers. Lindsay RS; Walker JD; Halsall I; Hales CN; Calder AA; Hamilton BA; Johnstone FD; J Clin Endocrinol Metab; 2003 Apr; 88(4):1664-71. PubMed ID: 12679454 [TBL] [Abstract][Full Text] [Related]
5. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Haffner SM; Gonzalez C; Mykkänen L; Stern M Diabetologia; 1997 Jul; 40(7):830-7. PubMed ID: 9243105 [TBL] [Abstract][Full Text] [Related]
6. Intact insulin, insulin propeptides, and intima-media thickness in the femoral artery in 58-year-old clinical healthy men--the Atherosclerosis and Insulin Resistance Study. Bokemark L; Wikstrand J; Fagerberg B; Angiology; 2001 Apr; 52(4):237-45. PubMed ID: 11330505 [TBL] [Abstract][Full Text] [Related]
7. Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarction. Gray RP; Panahloo A; Mohamed-Ali V; Patterson DL; Yudkin JS Atherosclerosis; 1997 Apr; 130(1-2):171-8. PubMed ID: 9126661 [TBL] [Abstract][Full Text] [Related]
8. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101 [TBL] [Abstract][Full Text] [Related]
9. Proinsulin and insulin concentrations following intravenous glucose challenges in normal, obese, and non-insulin-dependent diabetic subjects. Davis SN; Piatti PM; Monti L; Brown MD; Branch W; Hales CN; Alberti KG Metabolism; 1993 Jan; 42(1):30-5. PubMed ID: 8446045 [TBL] [Abstract][Full Text] [Related]
10. Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients. Coifman R; Dalbosco IS; Russo EM; Moisés RS Braz J Med Biol Res; 1999 Jan; 32(1):67-72. PubMed ID: 10347771 [TBL] [Abstract][Full Text] [Related]
11. Are specific serum insulin levels low in impaired glucose tolerance and type II diabetes?: measurement with a radioimmunoassay blind to proinsulin, in the population of Wadena, Minnesota. Goetz FC; French LR; Thomas W; Gingerich RL; Clements JP Metabolism; 1995 Oct; 44(10):1371-6. PubMed ID: 7476300 [TBL] [Abstract][Full Text] [Related]
13. Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance. Shimizu M; Kawazu S; Tomono S; Ohno T; Utsugi T; Kato N; Ishi C; Ito Y; Murata K Diabetes Care; 1996 Jan; 19(1):8-11. PubMed ID: 8720525 [TBL] [Abstract][Full Text] [Related]
14. Relationships of insulin and intact and split proinsulin to haemostatic function in young men with and without coronary artery disease. Båvenholm P; Proudler A; Silveira A; Crook D; Blombäck M; de Faire U; Hamsten A Thromb Haemost; 1995 Apr; 73(4):568-75. PubMed ID: 7495060 [TBL] [Abstract][Full Text] [Related]
15. Association of insulin and insulin propeptides with an atherogenic lipoprotein phenotype. Båvenholm P; Karpe F; Proudler A; Tornvall P; Crook D; Hamsten A Metabolism; 1995 Nov; 44(11):1481-8. PubMed ID: 7476338 [TBL] [Abstract][Full Text] [Related]
16. Nutrition in pregnancy and the concentrations of proinsulin, 32-33 split proinsulin, insulin, and C-peptide in cord plasma. Godfrey KM; Robinson S; Hales CN; Barker DJ; Osmond C; Taylor KP Diabet Med; 1996 Oct; 13(10):868-73. PubMed ID: 8911780 [TBL] [Abstract][Full Text] [Related]
17. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Haffner SM; Bowsher RR; Mykkänen L; Hazuda HP; Mitchell BD; Valdez RA; Gingerich R; Monterossa A; Stern MP Diabetes; 1994 Dec; 43(12):1490-3. PubMed ID: 7958504 [TBL] [Abstract][Full Text] [Related]
18. The contribution of proinsulin and des-31,32 proinsulin to the hyperinsulinemia of diabetic and nondiabetic cirrhotic patients. Kruszynska YT; Harry DS; Mohamed-Ali V; Home PD; Yudkin JS; McIntyre N Metabolism; 1995 Feb; 44(2):254-60. PubMed ID: 7869924 [TBL] [Abstract][Full Text] [Related]
19. Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men--report from 27 years of follow-up study. Zethelius B; Byberg L; Hales CN; Lithell H; Berne C Diabetologia; 2003 Jan; 46(1):20-6. PubMed ID: 12637978 [TBL] [Abstract][Full Text] [Related]
20. Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus. Deacon CF; Schleser-Mohr S; Ballmann M; Willms B; Conlon JM; Creutzfeldt W Acta Endocrinol (Copenh); 1988 Dec; 119(4):549-54. PubMed ID: 3059740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]